 |
|
|
|
|
|
|
|
|
|
|
|
1 to 25 of 25 results |
|
 |
|
|
|
|
|
 |
|
|
|
|
Breitner J. on NEWS: Bapineuzumab Phase 3: Target Engagement, But No Benefit, The absence of clinical benefits is disappointing, but not surprising at this point, and the... 13 Sep 2012.
|
|
|
 |
|
|
Breitner J. on NEWS: Feeding Frenzy—Therapeutics Tap Tryptophan, Cathepsins, HDACs, Zinc, The primary outcome data from the reaZin study appear to be consistent with the proposed action... 10 Jun 2011.
|
|
|
|
|
|
Breitner J. on NEWS: NIH Calls for More (and Different) Research on Preventive Measures, Absence of proof is not proof of absence.
The committee's conclusions reflect the current... 13 May 2010.
|
|
|
|
|
|
Breitner J. on LIVE DISCUSSION: Leon Thal Symposium Webinar, CMS stands to benefit hugely from any successful development of efficacious interventions... 3 Nov 2008.
|
|
|
|
|
|
Breitner J. on LIVE DISCUSSION: Leon Thal Symposium Webinar, Two endpoints should not be a problem, if one of the endpoints is reduced incidence of dementia.... 3 Nov 2008.
|
|
|
|
|
|
Breitner J. on LIVE DISCUSSION: Leon Thal Symposium Webinar, If we have a chance to come back to methodologic dilemmas confronting Primary Prevention trials,... 3 Nov 2008.
|
|
|
|
|
|
Breitner J. on LIVE DISCUSSION: Differential Neuronal Vulnerability, My thoughts are that this as a very interesting approach. It
capitalizes on our understandings... 22 Aug 2006.
|
|
|
|
|
|
Breitner J. on PAPER: Shah RC. et al., 2006, Further evidence that RECENT blood pressure measures are not related to occurrence of AD or... 4 Nov 2005.
|
|
|
|
|
|
Breitner J. on PAPER: Moonis M. et al., 2005, This, and other important work in a similar vein, suggests that "Alzheimerization" of brain... 31 Jul 2005.
|
|
|
|
|
|
Breitner J. on PAPER: Dietrich M. et al., 2005, Will the real mechanism by which ApoE4 accelerates expression of AD please stand up? 31 Jul 2005.
|
|
|
|
|
|
Breitner J. on PAPER: Yip AG. et al., 2005, Another candidate explanation for the profound effect of APOE polymorphism on risk of AD. 31 Jul 2005.
|
|
|
|
|
|
Breitner J. on PAPER: Yoshiura T. et al., 2005, Recommendation Only. 31 Jul 2005.
|
|
|
|
|
|
Breitner J. on PAPER: Puzzo D. et al., 2005, Recommendation Only. 31 Jul 2005.
|
|
|
|
|
|
Breitner J. on PAPER: Qiu C. et al., 2005, Recommendation Only. 31 Jul 2005.
|
|
|
|
|
|
Breitner J. on PAPER: Brinton RD. et al., 2005, This interesting hypothesis may well explain the apparent discord between human observational... 26 Jul 2005.
|
|
|
|
|
|
Breitner J. on PAPER: Snyder EM. et al., 2005, Recommendation Only. 22 Jul 2005.
|
|
|
|
|
|
Breitner J. on PAPER: Choi DK. et al., 2005, Recommendation Only. 22 Jul 2005.
|
|
|
|
|
|
Breitner J. on PAPER: Yagami T. et al., 2005, Given the termination of ADAPT, it may be many years before we know whether nonsteroidal drugs... 18 Jul 2005.
|
|
|
|
|
|
Breitner J. on NEWS: Merck Withdraws Vioxx®, Alzforum subscribers have no doubt heard that Merck has withdrawn its blockbuster COX-2... 1 Oct 2004.
|
|
|
|
|
|
Breitner J. on NEWS: Philadelphia: All Is Not Well with the Statin Story, Tobias is right, of course. It is only through formal experiment that one can test such... 21 Jul 2004.
|
|
|
|
|
|
Breitner J. on NEWS: Philadelphia: All Is Not Well with the Statin Story, A point of clarification about my presentation: Prescribing bias could indeed account for some... 19 Jul 2004.
|
|
|
|
|
|
Breitner J. on PAPER: Höglund K. et al., 2004, The paper suggests that statin treatment (simvastatain and atorvastatin) has no major effect on... 19 Mar 2004.
|
|
|
|
|
|
Breitner J. on NEWS: Naproxen/Rofecoxib Trial Results Published, This is the fifth published trial of antiinflammatory treatments for disease modification or... 6 Jun 2003.
|
|
|
|
|
|
Breitner J. on NEWS: One Thumb Up on Dietary Fat, One Down on Vitamins, Two Down on Estrogen, Estrogen may be helpful after menopause, but less so once there is neuronal stress. Two... 24 Feb 2003.
|
|
|
|
|
|
Breitner J. on NEWS: Early Clinical Results of Cox 2 Inhibitor: No Pain, No Gain?, This is the third small report of a trial of a non-steroidal anti-inflammatory drug (NSAID) for... 18 Apr 2002.
|
|
|
|
|
|
|
1 to 25 of 25 results |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
The ALS Forum is a web-based collaborative effort to bring together valuable ALS-related resources for use by researchers worldwide in both academia and industry-based settings.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Should the FDA be allowed to use data from overseas clinical trials? |
|
|
|
|
|
|
|
|
|
|
|
Absolutely, we are running out of viable subjects in the U.S. |
|
|
|
|
|
|
 9 |
|
|
|
|
|
|
|
|
|
|
|
Yes, so long as the data is reliable |
|
|
|
|
|
|
31 |
|
|
|
|
|
|
|
|
|
|
|
No, the trials are not as rigorous |
|
|
|
|
|
|
3 |
|
|
|
|
|
|
|
|
|
|
|
No, the data should be repeated in the U.S. |
|
|
|
|
|
|
5 |
|
|
|
|
|
|
|
|
|
|
|
No, the drug sponsors are just trying to cut corners |
|
|
|
|
|
|
3 |
|
|
|
|
|
|
|
|
|
|
|
Responses: 51 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
Archived Polls |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
 Antibodies
Cell Lines
Collaborators
Papers
Research Participants
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Home
See our latest Webinar: 
